Rising awareness and diagnosis of nocturia create
opportunities for pharmaceutical companies to develop and market
effective treatment options.
WILMINGTON, Del., July 30,
2024 /PRNewswire/ -- The global nocturia
market is estimated to flourish at a CAGR of
8.0% from 2024 to 2034. Transparency Market Research
projects that the overall sales revenue for nocturia is
estimated to reach US$ 8.5
billion by the end of 2034.
A significant trend is the increased focus on patient-centric
care. Healthcare providers and pharmaceutical companies are
prioritizing patient education and support programs to enhance
understanding and management of nocturia. This approach aims to
improve treatment adherence and patient outcomes by empowering
individuals with the knowledge and tools to manage their condition
effectively.
Download Sample of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=49929
The integration of wearable technology and mobile health apps is
also gaining traction in the nocturia market. Wearable devices that
monitor bladder activity and sleep patterns, coupled with mobile
apps for tracking symptoms and medication adherence, enable
personalized and real-time management of nocturia. These
technologies facilitate better communication between patients and
healthcare providers, leading to more tailored and effective
treatment plans.
There is a growing emphasis on minimally invasive and
non-pharmacological treatments. Behavioral therapies, lifestyle
modifications, and interventions such as pelvic floor exercises are
being increasingly recommended alongside or in place of medication.
These approaches reduce the risk of side effects and provide
sustainable long-term management options for patients.
Nocturia Market: Competitive Landscape
The competitive landscape of the nocturia market is
characterized by intense rivalry among pharmaceutical giants,
biotechnology firms, and medical device companies. Key players like
Pfizer, Ferring Pharmaceuticals, and Allergan are investing heavily
in R&D to develop innovative treatments.
Start-ups and smaller companies are also emerging, focusing on
niche therapies and leveraging cutting-edge technologies. Strategic
collaborations, mergers, and acquisitions are common as companies
seek to expand their market presence and diversify their product
portfolios. Regulatory approvals and the introduction of generic
versions of existing medications further intensify competition,
driving the market towards more effective and affordable nocturia
management solutions. Some prominent players are as
follows:
- AbbVie Inc.
- Vantia Therapeutics
- Astellas Pharma Inc.
- Urigen Pharmaceuticals Inc.
- Sumitomo Pharma Co. Ltd.
- Ferring Pharmaceuticals
- Glenmark Pharmaceuticals
- Teva Pharmaceutical Industries Ltd.
- Avadel Pharmaceuticals plc
Product Portfolio
- Vantia Therapeutics focuses on developing novel treatments
for urological and gastrointestinal disorders. Their
leading products include VA106483 for nocturia and VA111913 for
irritable bowel syndrome, aiming to improve patient quality of life
through innovative and targeted therapeutic solutions.
- Astellas Pharma Inc. offers a comprehensive portfolio of
pharmaceuticals, with key products such as Xtandi for prostate
cancer, Prograf for organ transplants, and Myrbetriq for
overactive bladder. Their commitment to innovation drives
advancements in oncology, immunology, and urology, enhancing
patient care globally.
Key Findings of the Market Report
- Desmopressin is the leading drug type segment in the nocturia
market, widely used for its efficacy in reducing nighttime
urination.
- Nocturnal Polyuria is the leading indication type segment in
the nocturia market, driven by its high prevalence and significant
impact on patients.
- Retail pharmacies are the leading distribution channel segment
in the nocturia market, providing widespread access to medications
and treatment solutions.
Explore Sample of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=49929
Nocturia Market Report Scope:
Report
Coverage
|
Details
|
Forecast
Period
|
2024-2034
|
Base
Year
|
2020-2022
|
Size in 2023
|
US$ 3.7 Bn
|
Forecast (Value) in
2034
|
US$ 8.5 Bn
|
Growth Rate
(CAGR)
|
8.0 %
|
No. of
Pages
|
124
Pages
|
Segments
covered
|
By Drug Type, By
Indication Type, By Distribution Channel, By Region
|
Nocturia Market Growth Drivers & Trends
- Increasing prevalence of nocturia in the elderly fuels market
growth, driving demand for effective management and treatment
solutions tailored to this demographic.
- Enhanced focus on patient education and support programs
improves treatment adherence, leading to better outcomes and
increased market adoption.
- Development of therapies targeting multiple causes of nocturia
offers comprehensive symptom control, improving patient quality of
life and expanding treatment options.
- Integration of wearables and health apps for monitoring and
managing nocturia provides personalized care, fostering patient
engagement and adherence.
- Growing emphasis on behavioral therapies, lifestyle
modifications, and minimally invasive interventions offers
sustainable management options, reducing reliance on
medications.
Global Nocturia Market: Regional Profile
- This region leads due to its advanced healthcare
infrastructure, high awareness, and significant investment in
research and development. The prevalence of nocturia among the
aging population drives demand for innovative treatments and
management solutions.
- Europe follows closely, with a
robust healthcare system and a strong focus on patient education
and support. The region's aging demographic and increasing
healthcare expenditure is key drivers of market growth. European
initiatives on geriatric care contribute to rising demand for
nocturia treatments.
- The Asia Pacific region is
experiencing rapid market growth due to its expanding aging
population, increasing healthcare access, and rising awareness of
nocturia. Economic development and improving healthcare
infrastructure in countries like China, Japan,
and India are significant
contributors to market expansion. The region's focus on integrating
traditional and modern medical practices also offers unique growth
opportunities.
Nocturia Market: Key Segments
By Drug Type
- Anticholinergic Drugs
- Desmopressin
- Antibiotics
- Antispasmodic
- Others
By Indication Type
- Mixed Nocturia
- Low Nocturnal Bladder Capacity
- Nocturnal Polyuria
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Buy this Premium Research Report:
https://www.transparencymarketresearch.com/checkout.php?rep_id=49929<ype=S
More Trending Report by Transparency Market Research:
- Oral Rehydration Solution [ORS] Market to Exceed
USD 6.71 billion by 2031, Capturing a
9.9% CAGR
- Pharmaceutical Contract Sales Outsourcing [CSO] Market
is Estimated to Register Growth at a CAGR of 7% by
2031.
- Losartan Market is expected to grow at a CAGR of 4.0%
from 2024 to 2034 and reach US$ 2.3
Bn by the end of 2034.
- Hydroxyapatite Market is projected to grow at a CAGR of
6.0% from 2024 to 2034 and reach more than US$ 4.4 Bn by the end of 2034.
About Transparency Market Research
Transparency Market Research, a global market
research company registered at Wilmington, Delaware, United States, provides custom research and
consulting services. Our exclusive blend of quantitative
forecasting and trends analysis provides forward-looking insights
for thousands of decision makers. Our experienced team of Analysts,
Researchers, and Consultants use proprietary data sources and
various tools & techniques to gather and analyses
information.
Our data repository is continuously updated and revised by a
team of research experts, so that it always reflects the latest
trends and information. With a broad research and analysis
capability, Transparency Market Research employs rigorous primary
and secondary research techniques in developing distinctive data
sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER
DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware
19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free:
866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn | Twitter
| Blog | YouTube
Logo:
https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/nocturia-market-to-reach-us-8-5-billion-by-2034--fueled-by-the-integration-of-wearable-technology-and-mobile-health-apps--transparency-market-research-inc-302209834.html
SOURCE Transparency Market Research